Verum Health
Longevity / Immune Protocol

Thymosin Alpha-1 · 5ML

Thymosin Alpha-1 is a thymic peptide studied for immune modulation, T-cell activation, and cancer surveillance. Physician-reviewed. Prescription required.

Longevity Immune Prescription Required
What It Is
Thymosin Alpha-1 5ML

Mechanism of Action

Thymosin Alpha-1 is a naturally occurring immunoregulatory peptide originally isolated from the thymus. It primarily acts as a modulator of innate and adaptive immunity. Its mechanisms involve enhancing immune cell function, regulating cytokine production, and improving immune surveillance.

Tα1 activates T cells, dendritic cells, and NK cells while modulating cytokine expression and Toll-like receptor (TLR) pathways. Its immune-restoring properties have been studied in the context of chronic infection, post-illness recovery, and longevity protocols. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.

Mechanism Biological Effect
T cell and dendritic cell activation Enhanced adaptive immunity
Cytokine modulation Balanced immune response
NK cell stimulation Stronger innate immunity
TLR pathway activation Enhanced pathogen recognition
Immune restoration Reconstitution of immunodeficient states
Anti-tumor immune enhancement Supports cancer surveillance
Candidate Profile

Who It's Designed For

Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with Thymosin Alpha-1 protocol candidates in clinical practice:

Immune Optimization

Individuals with physician-confirmed immune dysfunction or senescence seeking Tα1 support.

Post-Illness Recovery

Individuals recovering from chronic infection or immune-depleting illness under physician supervision.

Longevity Protocol

Individuals pursuing physician-reviewed immune system longevity support.

Cancer Surveillance

Individuals with physician oversight seeking immune surveillance enhancement as part of a longevity protocol.

Determine your candidacy

A physician will review your intake and make eligibility determination within 24–48 hours.

Outcomes & Timeline

What the Clinical Literature Indicates

All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.

Weeks 1–4
Early-stage signaling activity may be observed. Individual outcomes may differ. Physician monitoring recommended.
Weeks 4–8
In clinical and preclinical settings, progressive effects have been associated with continued administration. Results vary by individual.
Weeks 8–12
Sustained physician-supervised administration may support continued outcomes. Your physician will evaluate protocol continuation.
Dosing Overview

Protocol Structure

Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.

Typical Range

1.6 mg 2x/week

Administration

Subcutaneous injection

Duration

12–26 weeks (physician-determined)

Frequency

Twice weekly (physician-determined)

These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.

What's Included

Your Protocol Package

Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD

Valid prescription — Issued by your attending physician upon protocol approval

Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner

Follow-up check-in — Physician review at protocol midpoint; reorder pathway established

Clinical Considerations

Contraindications & Safety Notes

Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.

Active autoimmune disease: Tα1 stimulates immune activity. Use in autoimmune contexts requires careful physician evaluation.
Pregnancy or lactation: Not indicated. Contraindicated.
Immunosuppressive therapy: Potential interactions reviewed during physician consultation. Disclose all medications.
Current medications: Disclose all medications and supplements at intake.
FAQ

Common Questions

This compound is not FDA-approved as a drug. It is dispensed as a compounded medication through licensed 503A compounding pharmacies operating under FDA guidelines. All Verum Health protocols require a valid physician prescription.
After completing your HIPAA-secure health intake, a physician or NP will review your medical history, current medications, goals, and contraindications. If you're a candidate, a virtual consultation is scheduled — typically 15–20 minutes. Turnaround is 24–48 hours from intake submission.
Protocol stacking is reviewed on a case-by-case basis during your physician consultation. Any combination protocol is evaluated for safety and clinical appropriateness. Do not combine protocols without explicit physician guidance.
Reorders are managed through your patient portal. A follow-up physician check-in is required at protocol completion before continuation is authorized. Reorder notification is sent 10 days before your protocol completes.
Thymosin Alpha-1
VERUM HEALTH
From $180
Prescription required
Begin Consultation
How it works:
Add to cart → complete physician intake → doctor reviews within 24–48h → approval → pharmacy ships direct.
Refill Policy: Approved protocols include 4 months of refills. Auto-refill available after initial approval.